NewcelX Ltd. (NCEL)
NASDAQ: NCEL · Real-Time Price · USD
3.640
+0.030 (0.83%)
At close: Dec 5, 2025, 4:00 PM EST
3.330
-0.310 (-8.52%)
After-hours: Dec 5, 2025, 5:40 PM EST
Company Description
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.
NewcelX Ltd.
| Country | Switzerland |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Ronen Twito |
Contact Details
Address: The Circle 6 Zurich, 8058 Switzerland | |
| Website | newcelx.com |
Stock Details
| Ticker Symbol | NCEL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| CIK Code | 0001783036 |
| CUSIP Number | 001128461 |
| ISIN Number | IL0011284614 |
Key Executives
| Name | Position |
|---|---|
| Ronen Twito | Chief Executive Officer |
| Uri Ben-Or | Chief Financial Officer |